Founderland Logofounderland
the ★ top ★ 100 ★ marketers ★
SavedSearch
FoundersFounders
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Product Launches
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Investment News
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
Research & Innovation
Industries
Fintech iconFintechClimate / Social Tech iconClimate / Social TechSaaS iconSaaSHealthtech & Biotech iconHealthtech & BiotecheCommerce iconeCommerceMedia & Entertainment iconMedia & Entertainment
FoundersFounders
4136

Max Ludwig Ahnen

Logo
Max Ludwig Ahnen
CEO & Co-Founder of
Positrigo (2018)
About

Max Ludwig Ahnen is Co-Founder of Positrigo, an ETH Zurich spin-off pioneering ultra-compact brain PET imaging technology, where he served in roles spanning CEO, COO, and Chief Science Officer over nearly seven years.

Before founding

Max holds a Doctor of Sciences from ETH Zurich and a Diplom-Physiker degree from the Technical University of Munich, developing deep expertise in particle physics that he translated directly into medical imaging innovation.

Founder Insights

Max co-developed the BPET clinical prototype within ETH Zurich's Institute for Particle Physics and Astrophysics, and led Positrigo through regulatory milestones, clinical trials, and multiple funding rounds, earning the Venture Kick Stage I, II, and III awards totaling CHF 130,000.

Experience

At Positrigo, Max navigated the full MedTech journey from whiteboard to certified product, collaborating with University Hospital Zurich and securing backing from the European Innovation Council, 4FO Ventures, and Zurich Cantonal Bank.

Scale & Impact

Positrigo raised $18.2M across nine funding rounds and developed NeuroLF, a brain PET scanner one-fifth the size and one-tenth the cost of traditional systems, aiming to make early Alzheimer's diagnosis accessible to hospitals worldwide.

4136

Max Ludwig Ahnen

Positrigo
Co-Founder
Logo
Max Ludwig Ahnen

Company(s)

Positrigo

Industry

Healthtech & Biotech

Year Founded

2018

Stage/Funding

Series C • $18.2M

Company Location

ch

Connect

About

Max Ludwig Ahnen is Co-Founder of Positrigo, an ETH Zurich spin-off pioneering ultra-compact brain PET imaging technology, where he served in roles spanning CEO, COO, and Chief Science Officer over nearly seven years.

Before founding

Max holds a Doctor of Sciences from ETH Zurich and a Diplom-Physiker degree from the Technical University of Munich, developing deep expertise in particle physics that he translated directly into medical imaging innovation.

Founder Insights

Max co-developed the BPET clinical prototype within ETH Zurich's Institute for Particle Physics and Astrophysics, and led Positrigo through regulatory milestones, clinical trials, and multiple funding rounds, earning the Venture Kick Stage I, II, and III awards totaling CHF 130,000.

Experience

At Positrigo, Max navigated the full MedTech journey from whiteboard to certified product, collaborating with University Hospital Zurich and securing backing from the European Innovation Council, 4FO Ventures, and Zurich Cantonal Bank.

Scale & Impact

Positrigo raised $18.2M across nine funding rounds and developed NeuroLF, a brain PET scanner one-fifth the size and one-tenth the cost of traditional systems, aiming to make early Alzheimer's diagnosis accessible to hospitals worldwide.

About

Dreamwell AIContact UsOur Story

Articles

Product LaunchesInvestment NewsResearch & Innovation

founderland

We Use Cookies

We baked up some cookies – the digital kind. They help Draper run like a well-oiled mid-century machine. Some are essential to the experience, others help us tailor things to your taste. We promise, no crumbs on your blazer. Take a moment to choose what works for you.